Shop
Cart Details

Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 Mg - 150 Mg - 200 Mg - 10 Mg Tablet Bottle 30 Tablets

  • Manufacturer Name : GILEAD SCIENCES
  • MFG # : 61958190101
  • NDC : 61958190101
  • Distributor Name : Cardinal - SAGEBRUSH
PID UOM Price Qty

You are not eligible to purchase this product. Please contact your account manager for more information.

Register For Member Price

 

Additional Information

Product NameGenvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 Mg - 150 Mg - 200 Mg - 10 Mg Tablet Bottle 30 Tablets
ApplicationHIV Integrase Inhibitor
Generic Drug NameElvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide
Mechanism of ActionElvitegravir inhibits integrase, Cobicistat enhances drug levels, Emtricitabine and Tenofovir inhibit reverse transcription
Dosage FormTablet
Strength150 mg Elvitegravir, 150 mg Cobicistat, 200 mg Emtricitabine, 10 mg Tenofovir Alafenamide
Dosing FrequencyOnce daily with food
Common Side EffectsDiarrhea, headache, nausea, fatigue, upper respiratory tract infections
Serious Adverse EffectsKidney dysfunction, liver toxicity, lactic acidosis, bone mineral density loss
Container TypeBottle
Quantity30 Tablets
IndicationsHIV-1 infection treatment in adults and pediatric patients (=35 kg)

Description

Genvoya® is a fixed-dose combination tablet containing elvitegravir (150 mg), cobicistat (150 mg), emtricitabine (200 mg), and tenofovir alafenamide (10 mg). Genvoya® can be used as a complete regimen for treatment-naïve patients or as a replacement therapy for patients who are virologically suppressed on a stable antiretroviral (ARV) regimen for at least 6 months, with no history of treatment failure or resistance to any of the components.

Each tablet is green, capsule-shaped, and film-coated, with "GSI" debossed on one side and "510" on the other. Genvoya® works by combining the actions of four antiretroviral agents: elvitegravir inhibits the integrase enzyme, cobicistat acts as a pharmacokinetic enhancer to boost elvitegravir levels, while emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs) that prevent viral replication.

The recommended dosage of Genvoya® is one tablet taken once daily with food. It is important to adhere to the prescribed regimen to maintain viral suppression and prevent the development of resistance. Regular monitoring of kidney function and liver enzymes is recommended, as adverse effects may occur.

Frequently Asked Questions(FAQs)

The cost of Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 Mg - 150 Mg - 200 Mg - 10 Mg Tablet Bottle 30 Tablets is available for registerd members only .
Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 Mg - 150 Mg - 200 Mg - 10 Mg Tablet Bottle 30 Tablets is manufactured by GILEAD SCIENCES.
Read More

Subscribe to Our Newsletter